Director Miyazaki Invited to Speak at the Japanese Society for Dialysis Therapy.

68th Annual Meeting of the Japanese Society for Dialysis Therapy
Special Lecture

• Date: June 18, 2023 (Sunday) 10:40-11:40
• Venue: Kobe Convention Center
• Title: Significance of Blood Protein AIM in the Diagnosis and Treatment of End-Stage Chronic Kidney Disease

Director Miyazaki and Vice Director Arai will give an oral presentation at the 3rd RESOLUTION DAYS.

3rd RESOLUTION DAYS

• Date: April 27, 2023
• Venue: Hôtel Mercure Besancon Parc Micaud (Besancon, France)
• Title: Facilitation of disease repair through phagocytic removal of different inflammatory elements by AIM/CD5L

At the 56th Annual Meeting of the Japan Society for Clinical Renal Transplantation, Director Toru Miyazaki delivered a special lecture.

Event Details

• Date: February 12, 2023 (Sunday)
• Venue: The Okura Tokyo
• Topic: Diagnostic and Therapeutic Significance of AIM in End-stage Kidney Disease (ESKD)

Vice Director Arai^※ will participate as an organizer and speaker in a symposium at the 100th Anniversary Annual Meeting of the Physiological Society of Japan.

The 100th Anniversary Annual Meeting of the Physiological Society of Japan

• Presentation Date: March 15, 2023 (Wednesday)
• Venue: Kyoto International Conference Center
• Symposium Theme: Understanding Chronic Inflammatory Diseases from a Metabolic Perspective
• Presentation Title: Therapeutic and Diagnostic Impacts of AIM on Refractory Chronic Diseases

※Affiliated with the Graduate School of Medicine, the University of Tokyo

Vice Director Arai^※ Presented as Symposium Chair and Speaker at the 51st Annual Meeting of the Japanese Society for Immunology.

51st Annual Meeting of the Japanese Society for Immunology

• Presentation Date: December 7, 2022 (Wednesday)
• Venue: Kumamoto Castle Hall
• Symposium Theme: Introduction to innovative science for "resolution of inflammation"

※Presenting as a member of the University of Tokyo, Graduate School of Medicine

We are pleased to announce that our institute has been designated as a research institution under Article 2 of the Regulations for the Handling of Grants-in-Aid for Scientific Research by the Ministry of Education, Culture, Sports, Science and Technology (MEXT).

Moving forward, we will continue to advance our research activities based on the established "Operation and Management of Public Research Funds and Measures Against Research Misconduct" framework within the institute.

Director Miyazaki delivered a keynote lecture at the 10th International Conference on Legionella.

The 10th International Conference on Legionella

Keynote Lecture 2

• Date: September 21, 2022
• Venue: Hamagin Hall VIA MARE (Kanagawa, Japan)
• Title: A novel paradigm for disease therapy based on the self-pathogen removal system by AIM

Director Miyazaki and Vice Director Arai^※ gave oral presentations at the EMBO Workshop.

EMBO Workshop

• Date: September 15, 2022
• Venue: Thagaste Monastery (Ghent, Belgium)
• Title: Phagocytic removal of body-derived inflammatory elements and disease repair promoted by AIM

※Affiliated with the Graduate School of Medicine, University of Tokyo

We are pleased to announce that AIM Research, represented by Toru Miyazaki, has been chosen for the 2022 edition of the Charter of the Gutenberg Chairs, an initiative by Cercle Gutenberg in France to support medical research. This collaboration will be conducted in partnership with the University of Strasbourg to advance disease research.